Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

174
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.

Diabetes care·2026
Same author

Beyond access: Racial and socioeconomic disparities in device use among youth with type 1 diabetes.

SSM. Qualitative research in health·2026
Same author

Exploring Treatment Mechanisms of the Resilient, Empowered, Active Living-Telehealth (REAL-T) Intervention.

Canadian journal of occupational therapy. Revue canadienne d'ergotherapie·2026
Same author

Does today's workload predict tomorrow's stress, fatigue, and other strain states? Exploring directionality in daily dynamics.

Ergonomics·2026
Same author

Spiritual care for Latinx youth with type 1 diabetes (T1D) and their caregivers: qualitative analysis of focus groups.

Diabetology & metabolic syndrome·2026
Same author

DiaBetter Together: Outcomes of a Randomized Controlled Trial Evaluating a Peer Mentor Behavioral Intervention for Young Adults With Type 1 Diabetes During the Transfer From Pediatric to Adult Care.

Diabetes care·2026

Related Experiment Video

Updated: Jul 4, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.8K

Young Adults with Type 1 Diabetes.

Priyanka Mathias1, Sarah D Corathers2, Samantha A Carreon3

  • 1Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, 1180 Morris Park Avenue, Bronx, NY 10467, USA.

Endocrinology and Metabolism Clinics of North America
|January 25, 2024
PubMed
Summary

Managing type 1 diabetes during young adulthood is challenging due to life transitions. This review covers outcomes, unique needs, and evidence-based strategies for improving care in this population.

Keywords:
Developmental challengesHealth-care transitionMarginalized youthTargeted interventionsType 1 diabetesYoung adults

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K

Related Experiment Videos

Last Updated: Jul 4, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K

Area of Science:

  • Endocrinology
  • Adolescent and young adult medicine
  • Public health

Background:

  • Young adults undergo significant life transitions (social, educational, vocational, residential, financial).
  • These transitions can compete with managing chronic conditions like type 1 diabetes.
  • Competing priorities may lead to adverse psychosocial and medical outcomes in young adults with type 1 diabetes.

Purpose of the Study:

  • To review population outcomes for young adults.
  • To highlight unique considerations for type 1 diabetes management in this age group.
  • To present evidence-based strategies and future recommendations for improving care.

Main Methods:

  • Narrative review of existing literature.
  • Synthesis of population outcomes and management considerations.
  • Identification of evidence-based care strategies.

Main Results:

  • Young adulthood presents distinct challenges for type 1 diabetes self-management.
  • Life transitions significantly impact adherence and health outcomes.
  • Current evidence supports targeted interventions for this demographic.

Conclusions:

  • Optimizing type 1 diabetes care requires addressing the specific developmental stage of young adults.
  • Future research should focus on tailored interventions and support systems.
  • Integrated care models are essential for improving long-term outcomes.